![Robert Sterling](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Sterling
Geen lopende functies
Profiel
Robert Sterling is Vice President of Business Development for Bioenvision, Inc. Prior to joining Bioenvision in December, 2001, he held various marketing and sales positions at Hoechst Roussel Vet Gmbh.
Mr. Sterling received a BS degree from Pennsylvania State University.
Eerdere bekende functies van Robert Sterling
Bedrijven | Functie | Einde |
---|---|---|
Hoechst Roussel Vet Gmbh
![]() Hoechst Roussel Vet Gmbh Pharmaceuticals: OtherHealth Technology Part of Merck & Co., Inc., Hoechst Roussel Vet Gmbh develops pharmaceutical products for animals. The company is based in Hessen, Germany. Hoechst Roussel Vet was acquired by Intervet International BV from Hoechst AG on August 11, 1999 for $713.99 million. | Corporate Officer/Principal | - |
Bioenvision, Inc.
![]() Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Opleiding van Robert Sterling
The Pennsylvania State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Bioenvision, Inc.
![]() Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Hoechst Roussel Vet Gmbh
![]() Hoechst Roussel Vet Gmbh Pharmaceuticals: OtherHealth Technology Part of Merck & Co., Inc., Hoechst Roussel Vet Gmbh develops pharmaceutical products for animals. The company is based in Hessen, Germany. Hoechst Roussel Vet was acquired by Intervet International BV from Hoechst AG on August 11, 1999 for $713.99 million. | Health Technology |